BCMU
TBRA

BlueCrest Capital Management (UK)’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,478
Closed -$167K – 782
2014
Q1 		$167K Buy
+1,478
New +$104K 0.01% 474

Other funds holding TBRA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIA
Biondo Investment Advisors Milford, Pennsylvania $780M AUM 21.03% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return

BlueCrest Capital Management (UK)'s TBRA Position: Q2 2014 in Review

BlueCrest Capital Management (UK) sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q2 2014, closing a stake of 1,478 shares — an estimated $167K sold.

BlueCrest Capital Management (UK) first reported a position in TBRA in Q1 2014 and held it in 1 quarter. The position peaked at $167K in Q1 2014. 49 funds tracked by Wall St. Rank hold TBRA as of Q2 2014.

  • BlueCrest Capital Management (UK) reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • BlueCrest Capital Management (UK) sold 1,478 Tobira Therapeutics, Inc. Common Stock shares in Q2 2014, an estimated $167K.
  • BlueCrest Capital Management (UK) first reported a position in Tobira Therapeutics, Inc. Common Stock in Q1 2014 and held it in 1 quarter.
  • BlueCrest Capital Management (UK)'s Tobira Therapeutics, Inc. Common Stock position peaked at $167K in Q1 2014.
  • 49 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q2 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q2 2014, filed 15 Aug 2014.